Page 155 - IJB-8-4
P. 155

Yang, et al.
            A                       B                                        C















           D                     E                       F
                                                                                G
















           Figure 1. Schematic illustration of constructing the in vitro skin equivalent using rhCol3-based bioinks and 3D bioprinting, together with an
           in vivo test. (A) The content of type I and III collagen to the total collagens presented in the human skin. (B) Preparation of the rhCol3-based
           bioink formulations consisting of base component GelMA, bioactive rhCol3, and photoinitiator LAP. (C) 3D bioprinting of the HDFs-laden
           dermal constructs on a transwell followed by photocrosslinking. (D) Seeding of HaCaTs on top of printed dermal constructs. (E) Submerge
           culturing of the in vitro 3D skin tissue. (F) Air-liquid interface culturing process to obtain the differentiated epidermal layer. (G) In vivo test
           of the biocompatibility of the GelMA-rhCol3 bioinks.

           GelMA-rhCol3 mimicked skin tissue microenvironment   GelMA solutions and stirred for 1 h until fully dissolved.
           that supports skin cell adhesion, migration, proliferation,   The mixtures were then filtered through 0.22 μm filters
           and differentiation, which are critical processes involved   and collected  in lightproof universal tubes for further
           in skin repair and regeneration.                    use. The composite bioinks prepared in this study were
                                                               differentiated corresponding to the concentration of rhCol3
           2. Materials and methods                            while  fixing  the  GelMA  concentration  at  7.5  wt%.  The
           2.1. Preparation of GelMA and GelMA-rhCol3          composite bioinks were named GelMA-rhCol3 – 0.8, 1.6,
           bioinks                                             and 3.2 corresponding to the concentration of rhCol3 (0.8,
                                                               1.6, and 3.2 wt%) within the bioinks.
           GelMA solutions at concentrations of 5, 7.5, and 10 wt%
           were prepared by fully dissolving the GelMA powder   2.2. Cell culture
           (SunP Gel-G1, degree of substitution 55 – 65%, porcine
           skin, 300 g bloom, SunP Biotech) in Dulbecco’s phosphate-  HaCaTs cell line and human dermal fibroblasts (HDFs)
           buffered saline (Wisent, Canada) that contains 0.25 wt%   were purchased from the National Infrastructure of Cell
           lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP,   Line Resource (NICR, Beijing). The HaCaTs and HDFs
           SunP Biotech) as photoinitiator. The GelMA solutions were   were  cultured  in  Dulbecco’s  Modified  Eagle  Medium
           sterilized by filtering through the 0.22 μm filter. GelMA   (DMEM; Wisent, Canada) supplemented with 10% fetal
           hydrogels were formed by treating the precursor solution   bovine  serum  (Gibco,  Beijing),  1%  GlutaMax  (Gibco,
           with 405 nm ultraviolet (UV) light (25 mW/cm ) for 20 s.   Beijing), 1% non-essential amino acids (Gibco, Beijing),
                                                  2
           To prepare the GelMA-rhCol3 bioinks, a predetermined   and  1%  penicillin-streptomycin  (Gibco,  Beijing).  The
           amount of type III recombinant human collagen powder   cells were passaged before reaching a confluence of 80 –
           (the National  Center for Biotechnology  Information   90%, with the culture medium changed every other day
           GenBank Access Number:  EF376007, kindly  provided   when culturing at 37°C and 5% CO . For HaCaTs cultured
                                                                                            2
           by  the  Bioengineering  Lab  of  Nanjing  University  of   on hydrogels in 24-well transwell inserts (Thermo
           Science  and  Technology, China)  was mixed  with the   Fisher  Scientific,  Denmark),  the  culture  medium  was

                                       International Journal of Bioprinting (2022)–Volume 8, Issue 4       147
   150   151   152   153   154   155   156   157   158   159   160